Financial Analysis: Procept BioRobotics Corp (PRCT)’s Ratios Unveil Key Insights

Seeking to outpace the market, investors engage in the art of selecting individual stocks. The right picks can play a pivotal role in boosting your wealth.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free
Sponsored

As of close of business last night, Procept BioRobotics Corp’s stock clocked out at $97.78, up 4.47% from its previous closing price of $93.60. In other words, the price has increased by $4.47 from its previous closing price. On the day, 0.54 million shares were traded. PRCT stock price reached its highest trading level at $97.88 during the session, while it also had its lowest trading level at $93.24.

Ratios:

To gain a deeper understanding of PRCT’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 5.07 and its Current Ratio is at 6.02. In the meantime, Its Debt-to-Equity ratio is 0.33 whereas as Long-Term Debt/Eq ratio is at 0.33.

Upgrades & Downgrades

In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Jefferies on November 14, 2024, initiated with a Hold rating and assigned the stock a target price of $95.

On August 11, 2023, Piper Sandler started tracking the stock assigning a Overweight rating and target price of $42.

Insider Transactions:

Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Nov 20 ’24 when Zadno Reza sold 26,420 shares for $92.57 per share. The transaction valued at 2,445,724 led to the insider holds 205,605 shares of the business.

REZA ZADNO bought 26,420 shares of PRCT for $2,472,119 on Nov 20 ’24. On Nov 13 ’24, another insider, Zadno Reza, who serves as the President, CEO of the company, sold 26,420 shares for $94.08 each. As a result, the insider received 2,485,573 and left with 232,025 shares of the company.

Valuation Measures:

Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, PRCT now has a Market Capitalization of 5290513920 and an Enterprise Value of 4770222080. For the stock, the TTM Price-to-Sale (P/S) ratio is 26.38 while its Price-to-Book (P/B) ratio in mrq is 21.14. Its current Enterprise Value per Revenue stands at 23.87 whereas that against EBITDA is -47.061.

Stock Price History:

Over the past 52 weeks, PRCT has reached a high of $103.81, while it has fallen to a 52-week low of $33.45. The 50-Day Moving Average of the stock is 18.20%, while the 200-Day Moving Average is calculated to be 47.81%.

Shares Statistics:

It appears that PRCT traded 816.58K shares on average per day over the past three months and 654500 shares per day over the past ten days. A total of 54.39M shares are outstanding, with a floating share count of 51.34M. Insiders hold about 5.61% of the company’s shares, while institutions hold 84.37% stake in the company. Shares short for PRCT as of 1730332800 were 5896747 with a Short Ratio of 7.22, compared to 1727654400 on 5516627. Therefore, it implies a Short% of Shares Outstanding of 5896747 and a Short% of Float of 14.739999000000001.

Most Popular